Stockreport

Spruce Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates [Yahoo! Finance]

Spruce Biosciences, Inc.  (SPRB) 
PDF Biologics License Application Submission of TA-ERT for the Treatment of MPS IIIB on Track for the First Quarter of 2026 Completed $50.0 Million Private Placement Fina [Read more]